Back

Advancements in ablation technology lead to improved durability and outcome of pulmonary vein isolation using radiofrequency energy

30 March 2025 (08:00 - 15:30)
Organised by: Logo
Congress Presentation Part of: Atrial fibrillation catheter ablation Rhythm Control, Catheter Ablation EHRA Premium Access EHRA 2025 European Heart Rhythm Association (EHRA)

About the speaker

Photo
Associate Professor Laszlo Saghy

University of Szeged, Szeged (Hungary)

5 More presentations in this session

Presentation thumbnail
Impact of ablate and pace on clinical outcomes, quality of life and healthcare utilization in patients with atrial fibrillation
Mrs M. Scheurwater (Eindhoven, NL)
Abstract Slides Video
Presentation thumbnail
Utilization trends of AF ablation among patients with physical disabilities
Doctor G. Margolis (Hadera, IL)
Abstract Slides Video
Presentation thumbnail
Impact of pre-procedural atrial fibrillation burden on recurrences after ablation: findings from the ISOLATION cohort study
Miss Z. Habibi (Maastricht, NL)
Abstract Slides Video
Presentation thumbnail
Catheter ablation for atrial fibrillation in patients with tricuspid regurgitation
Mr J. Bruegger (Basel, CH)
Abstract Slides Video
Presentation thumbnail
Catheter ablation of atrial fibrillation in patients with psoriasis: a multicenter study
Associate Professor M. Casella (Ancona, IT)
Abstract Slides Video

Access the full session

Session thumbnail
Atrial fibrillation catheter ablation

The Event

Event poster

EHRA 2025

30 March - 1 April 2025
You may be interested in
thumbnail
Congress Presentation
Atrial fibrillation re-ablation: a comparative analysis of the efficacy of initial PVI procedures
thumbnail
Congress Presentation
Characterising recurrent atrial fibrillation after catheter ablation: patterns of pulmonary vein reconnection and predictors of complete pulmonary vein isolation
thumbnail
Congress Presentation
Pulmonary vein isolation durability in patients undergoing very high-power short-duration temperature-controlled ablation.

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources